Published in Law and Health Weekly, June 24th, 2006
Study 1: Epoetin beta therapy increased hemoglobin (HB) in patients with solid tumors, regardless of the type of chemotherapy (CT) they received.
According to recent research published in the journal Anticancer Research, "Anaemia is a common complication of CT, including both non-platinum (Pt)-based as well as Pt-based CT3. Patients from 3 controlled trials with solid tumours receiving either Pt- or non-Pt-based CT, who had been randomised to epoetin beta treatment or standard care, were included in this meta-analysis (n=255, n=199, respectively), to see...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.